M1prime peptide from IgE bound by humanized antibody 47H4 Fab
Domain Annotation: ECOD Classification ECOD Database Homepage
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
|---|---|---|---|---|---|---|---|---|
| H [auth J] | PBP | e3hr5J1 | A: a/b three-layered sandwiches | X: Lipocalins/Streptavidin | H: Immunoglobulin-related | T: PEBP-like | F: PBP | ECOD (v294.1) |
| F [auth I] | PBP | e3hr5I1 | A: a/b three-layered sandwiches | X: Lipocalins/Streptavidin | H: Immunoglobulin-related | T: PEBP-like | F: PBP | ECOD (v294.1) |
| D [auth B] | PBP | e3hr5B1 | A: a/b three-layered sandwiches | X: Lipocalins/Streptavidin | H: Immunoglobulin-related | T: PEBP-like | F: PBP | ECOD (v294.1) |
| B [auth H] | MAPEG | e3hr5H1 | A: a/b three-layered sandwiches | X: Immunoglobulin-like beta-sandwich | H: MAPEG domain-like | T: MAPEG domain-like | F: MAPEG | ECOD (v294.1) |
| G [auth Q] | PBP | e3hr5Q1 | A: a/b three-layered sandwiches | X: Lipocalins/Streptavidin | H: Immunoglobulin-related | T: PEBP-like | F: PBP | ECOD (v294.1) |
| E [auth P] | PBP | e3hr5P1 | A: a/b three-layered sandwiches | X: Lipocalins/Streptavidin | H: Immunoglobulin-related | T: PEBP-like | F: PBP | ECOD (v294.1) |
| C [auth A] | PBP | e3hr5A1 | A: a/b three-layered sandwiches | X: Lipocalins/Streptavidin | H: Immunoglobulin-related | T: PEBP-like | F: PBP | ECOD (v294.1) |
| A [auth L] | PBP | e3hr5L1 | A: a/b three-layered sandwiches | X: Lipocalins/Streptavidin | H: Immunoglobulin-related | T: PEBP-like | F: PBP | ECOD (v294.1) |
Domain Annotation: CATH CATH Database Homepage
| Chain | Domain | Class | Architecture | Topology | Homology | Provenance Source (Version) |
|---|---|---|---|---|---|---|
| H [auth J] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| F [auth I] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| D [auth B] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| B [auth H] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| G [auth Q] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| E [auth P] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| C [auth A] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| A [auth L] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
IMGT Antibody Annotation IMGT Database Homepage
| Chain | Protein Name | Description | Organism Name | Gene Allele Name(s) | Domain Name(s) | Receptor Type | Receptor Description | Provenance Source |
|---|---|---|---|---|---|---|---|---|
| B [auth H], D [auth B], F [auth I], H [auth J] | quilizumab, 47H4, Anti-M1', MEMP1972A, RG-7449 | VH-CH1 | Humanized (humanized) | IGHV3-48*01, IGHV3-48*03, IGHV3-48*04, IGHJ3*01, IGHJ3*02, IGHG1*01, IGHG1*02, IGHG1*04 | V-DOMAIN VH, C-DOMAIN CH1 | IG | FAB-GAMMA-1_KAPPA | IMGT (202611-0) |
| A [auth L], C [auth A], E [auth P], G [auth Q] | quilizumab, 47H4, Anti-M1', MEMP1972A, RG-7449 | L-KAPPA | Humanized (humanized) | IGKV1-5*03, IGKV1-39*01, IGKV1D-39*01, IGKJ1*01, IGKC*01 | V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA | IG | FAB-GAMMA-1_KAPPA | IMGT (202611-0) |
SAbDab Antibody Annotation SAbDab Database Homepage
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|---|---|---|---|---|
| B [auth H], D [auth B], F [auth I], H [auth J] | Heavy Chain | IGHV3 | - | m1prime-derived peptide | SAbDab (2026-03-27) |
| A [auth L], C [auth A], E [auth P], G [auth Q] | Light Chain | IGKV1 | Kappa | m1prime-derived peptide | SAbDab (2026-03-27) |
Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage
| Chain | Name | Target | Provenance Source |
|---|---|---|---|
| B [auth H], D [auth B], F [auth I], H [auth J] | Quilizumab | IGHE | Therapeutic SAbDab (2026-03-27) |
| A [auth L], C [auth A], E [auth P], G [auth Q] | Quilizumab | IGHE | Therapeutic SAbDab (2026-03-27) |














